Goodwin Procter advised Minovia Therapeutics on the deal. Minovia Therapeutics announced its worldwide strategic collaboration and license agreement with Astellas Pharma (TSE: 4503) to research, develop, and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Schrödinger on the deal. Schrödinger (Nasdaq: SDGR) announced its global discovery, development and commercialization collaboration with Zai Lab Limited focused on a novel program...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) and its affiliate QED Therapeutics, Inc. announced a global collaboration and licensing...
You must be a Standard 1 Year member to access this content.
